REVIEW PAPER
Betulin and betulinic acid in cancer research
 
More details
Hide details
1
Chair and Department of Medical Chemistry, Medical University, Lublin, Poland
CORRESPONDING AUTHOR
Anna Hordyjewska   

Chair and Department of Medical Chemistry, Medical University, Chodźki Street 4a, 20-093 Lublin, Poland
 
J Pre Clin Clin Res. 2018;12(2):72–75
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Terpenes are the largest known class of organic compounds, widely distributed in plants. They are grouped considering the number of isoprene units in their structure; hence, the group consisting of 30 carbon atoms is called triterpenes. These compounds have a wide range of biological features.

Objective:
The aim of this review was to comprehensively discuss the role of betulin and betulinic acid as potent anticancer agents, including various studies determining their efficiency in cancer treatment and enumerating the types of cancer susceptible to this kind of therapy.

State of knowledge:
Betulin is a naturally occurring lupane-type pentacyclic triterpene, wildly distributed in plants, especially Betulinaceae. One of its derivatives, formed by oxidation, is betulinic acid. Both compounds are abundantly present in the outer bark of white birch, with betulin forming up to 34% its dry mass and are known for their valuable biological properties, including anti-cancer effect. By inducing the internal apoptosis pathway in cancer cells while sparing normal cells, they are a great help in the treatment of most malignancies, alone or in combination with radio- or chemotherapy.

Summary:
Compounds that have a direct effect on mitochondria are promising experimental anticancer drugs, since they are able to cause cell death in conditions in which conventional therapies, including chemotherapeutics, usually fail. Therefore, mitochondrial targeting agents such as betulin and betulinic acid are a promise of a new therapeutic strategy for the treatment of human tumours.

 
REFERENCES (37)
1.
Breitmaier E. Terpenes: Importance, General Structure, and Biosynthesis. 2006.
 
2.
Rabi T, Bishayee A. Terpenoids and breast cancer chemoprevention. Breast Cancer Res Treat. 2009;115(2):223-239.
 
3.
Withers ST, Keasling JD. Biosynthesis and engineering of isoprenoid small molecules. Appl Microbiol Biotechnol. 2007;73(5):980-990.
 
4.
Liby KT, Yore MM, Sporn MB. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer. 2007;7(5):357-369.
 
5.
Bishayee A, Ahmed S, Brankov N, Perloff M. Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Front Biosci. 2011;16(1):980.
 
6.
Krajcovicova Z, Vachálková A, Horváthová K, Tóthová D. Pentacyclic Triterpenoic Acids: New Chemoprotective Compounds. Minireview. Neoplasma. 2004;51:327-333.
 
7.
Hsu T-I, Chen Y-J, Hung C-Y, Wang Y-C, Lin S-J, Su W-C et al. A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy. Oncotarget. 2015;6(15):13671-13687.
 
8.
Phillips DR, Rasbery JM, Bartel B, Matsuda SP. Biosynthetic diversity in plant triterpene cyclization. Curr Opin Plant Biol. 2006;9(3):305-314.
 
9.
Petronellia A, Pannitterib G, Testaa U. Triterpenoids as new promising anticancer drugs. Anticancer Drugs. 2009;20(10):880-892.
 
10.
Laszczyk MN. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med. 2009;75(15):1549-1560.
 
11.
Alakurtti S, Mäkelä T, Koskimies S, Yli-Kauhaluoma J. Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci. 2006;29(1):1-13.
 
12.
Lin WY, Lin FH, Sadhasivam S, Savitha S. Antioxidant effects of betulin on porcine chondrocyte behavior in gelatin/C6S/C4S/HA modified tricopolymer scaffold. Mater Sci Eng C. 2010;30(4):597-604.
 
13.
Şoica CM, Dehelean CA, Peev C, Aluas M, Zupkó I, Kása Jr P. et al. Physico-chemical comparison of betulinic acid, betulin and birch bark extract and in vitro investigation of their cytotoxic effects towards skin epidermoid carcinoma (A431), breast carcinoma (MCF7) and cervix adenocarcinoma (HeLa) cell lines. Nat Prod Res. 2012;26(10):968-974.
 
14.
Chintharlapalli S, Papineni S, Ramaiah SK, Safe S. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 2007;67(6):2816-2823.
 
15.
Yogeeswari P, Sriram D. Betulinic Acid and Its Derivatives: A Review on their Biological Properties. Curr Med Chem. 2005;12(6):657-666.
 
16.
Newman D., Cragg G., Snader K. Natural Products as sources of New Drugs over the Period 1981 - 2002. J Nat Prod. 2003;66(7):1022-1037.
 
17.
Pisha E, Chai H, Lee I-S, Chagwedera TE. Farnsworth NHS, Cordell, GA et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med. 1995;1(10):1046-1051.
 
18.
Fulda S. Betulinic acid for cancer treatment and prevention. Int J Mol Sci. 2008;9(6):1096-1107.
 
19.
Drag M, Surowiak P, Drag-Zalesińska M, Dietel M, Lage H, Oleksyszyn J. Comparision of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drug-resistant cell lines. Molecules. 2009;14(4):1639-1651.
 
20.
Thurnher D, Turhani D, Pelzmann M, Wannemacher B, Knerer B, Formanek M et al. Betulinic acid: A new cytotoxic compound against malignant head and neck cancer cells. Head Neck. 2003;25(9):732-740.
 
21.
Wick W, Grimmel C, Wagenknecht B, Dichgans J, Weller M. Betulinic acid- induced apoptosis in glioma cells: a sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. J Pharmacol Exp Ther. 1999;289(3):1306–1312.
 
22.
Gao Y, Ma Q, Ma Y, Ding L, Xu X, Wei D. et al. Betulinic acid induces apoptosis and ultrastructural changes in MDA-MB-231 breast cancer cells. Ultrastruct Pathol. 2017;00(00):1-6.
 
23.
Jae SP, Si HR, Dae KK, Jin GL, Yong YL, Soon SH et al. Anti-cancer effect of betulin on a human lung cancer cell line: A pharmacoproteomic approach using 2 D SDS PAGE coupled with nano-HPLC tandem mass spectrometry. Planta Med. 2009;75(2):127-131.
 
24.
Sun Y, Song C, Viernstein H, Unger F, Liang Z. Apoptosis of human breast cancer cells induced by microencapsulated betulinic acid from sour jujube fruits through the mitochondria transduction pathway. Food Chem. 2013;138(2-3):1998-2007.
 
25.
Schmidt ML, Kuzmanoff KL, Ling-Indeck L, Pezzuto JM. Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur J Cancer. 1997;33(12):2007-2010.
 
26.
Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer. 2011;11(1):371.
 
27.
Zhang X, Hu J, Chen Y. Betulinic acid and the pharmacological effects of tumor suppression (Review). Mol Med Rep. 2016;14(5):4489-4495.
 
28.
Ehrhardt H, Fulda S, Führer M, Debatin KM, Jeremias I. Betulinic acid-induced apoptosis in leukemia cells. Leukemia. 2004;18(8):1406-1412.
 
29.
Rzeski W, Stepulak A, Szymański M, Juszczak M, Grabarska A, Sifringer M et al. Betulin Elicits Anti-Cancer Effects in Tumour Primary Cultures and Cell Lines in Vitro. Basic Clin Pharmacol Toxicol. 2009;105(6):425-432.
 
30.
Rzeski W, Stepulak A, Szymañski M, Sifringer M, Kaczor J, Wejksza K et al. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn Schmiedebergs Arch Pharmacol. 2006;374(1):11-20.
 
31.
Fulda S, Debatin K. Sensitization for Anticancer Drug-Induced Apoptosis by Betulinic Acid. Neoplasia. 2005;7(2):162-170.
 
32.
Sawada N, Kataoka K, Kondo K, Arimochi H, Fujino H, Takahashi Y et al. Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice. Br J Cancer. 2004;90(8):1672-1678.
 
33.
Selzer E, Pimentel E, Wacheck V, Schlegel W, Pehamberger H, Jansen B et al. Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells. J Invest Dermatol. 2000;vol 114: 935-940;.
 
34.
Zuco V, Supino R, Righetti SC, Unger F, Liang Z. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett. 2002;175(1):17-25.
 
35.
Zeng A-Q, Yu Y, Yao Y-Q, Yang F-F, Liao M, Song L-J et al. Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer models. Oncotarget. 2018;9(3):3794-3804.
 
36.
Shin YG, Cho KH, Chung SM, Graham J, Das Gupta TK, Pezzuto JM. Determination of betulinic acid in mouse blood, tumor and tissue homogenates by liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl. 1999;732:331–336.
 
37.
Jäger S, Laszczyk MN, Scheffler A. A Preliminary Pharmacokinetic Study of Betulin, the Main Pentacyclic Triterpene from Extract of Outer Bark of Birch (Betulae alba cortex). 2008:3224-3235.
 
eISSN:1898-7516
ISSN:1898-2395